Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pevonedistat + Azacitidine in MRD+ MDS/AML
NCT04712942Phase 2Completed
- Sponsor
- Leipzig University
- Start
- Jan 2021
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pevonedistat in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), sponsored by Leipzig University. Started Jan 2021; status: completed.
02
Drugs
pevonedistat
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT04712942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04712942.